Relative to the regulation of pharmacists-in-charge and pharmacies.
Relative to establishing a committee to study the impact of pharmacy benefit manager operations on cost, administration, and distribution of prescription drugs.
Relative to receipt of pharmaceutical rebates by insurers and pharmacy benefits managers.
Establishing a commission to study revisions to occupational regulation of pharmacists and pharmacies.
Relative to substitution of biological products by pharmacies.
Relative to state fees, funds, revenues, and expenditures.
Relative to the dispensing of certain medications.
Relative to allowing pharmacists to administer influenza, COVID-19, and other FDA licensed vaccines without explicit approval from the general court.
Relative to prescription drug assistance for individuals with diabetes.
Relative to provider contract standards for pharmacy benefit managers.